| Name: | Tenofovir NPOC POC PMPA |
| Catalogue No. | VL470008 |
| CAS No. | 1217542-13-6 |
| Molecular Formula | C19H30N5O10P |
| Molecular Weight | 519.44 |
| Status | In-stock |
| IUPAC Name | 5-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]- 2,4,6,8-tetraoxa-5-phosphanonanedethyl,propyl) Ester 5-Oxide |
| Synonyms | Tenofovir NPOC-POC PMPA |
| Description | Tenofovir NPOC POC PMPA (CAS No: 1217542-13-6) Or 5-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]- 2,4,6,8-tetraoxa-5-phosphanonanedethyl,propyl) Ester 5-Oxide, Tenofovir is nucleotide reverse transcriptase inhibitor, which is antiviral medicine that is used to treat HIV. |
| References | Sci-Hub | The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years | 10.1097/qad.0b013e3280b07b33. (2022). Retrieved January 24, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1097/qad.0b013e3280b07b33 |
